CoChat

The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.

Poor availability of essential medicines for women and children threatens progress towards Sustainable Development Goal 3 in Africa

Open access
Droti, Benson, O’Neill, Kathryn Patricia, Mathai, Matthews, Yao Tsidi Dovlo, Delanyo, Robertson, Jane · 2019 · BMJ Global Health

Abstract

Background: Most maternal and child deaths are preventable or treatable with proven, cost-effective interventions for infectious diseases and maternal and neonatal complications. In 2015 sub-Saharan Africa accounted for up to 66% of global maternal deaths and half of the under-five deaths. Access to essential medicines and commodities and trained healthcare workers to provide life-saving maternal, newborn and post-natal care are central to further reductions in maternal and child mortality. Methods: Available data for 24 priority medicines for women and children were extracted from WHO service availability and readiness assessments conducted between 2012 and 2015 for eight countries in sub-Saharan Africa. The mean availability of medicines in facilities stating they provide services for women or children and differences by facility type, ownership and location are reported. Results: The mean availability of 12 priority essential medicines for women ranged from 22% to 40% (median 33%; IQR 12%) and 12 priority medicines for children ranged from 28% to 57% (median 50%; IQR 14%). Few facilities (<1%) had all nominated medicines available. There was higher availability of priority medicines for women in hospitals than in primary care facilities: range 32%–80% (median 61%) versus 20%–39% (median 23%) and for children’s medicines 31%–71% (median 58%) versus 27%–57% (median 48%). Availability was higher in public than private facilities: for women’s medicines, range 21%–41% (median 34%) versus 4%–36% (median 27%) and for children’s medicines 28%–58% (median 51%) versus 5%–58% (median 46%). Patterns were mixed for rural and urban location for the priority medicines for women, but similar for children’s medicines. Conclusions: The survey results show unacceptably low availability of priority medicines for women and children in the eight countries. Governments should ensure the availability of medicines for mothers and children if they are to achieve the health sustainable development goals.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjgh-2018-001306

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Mean availability of the 12 essential medicines for women and children.
Figure 1 Mean availability of the 12 essential medicines for women and children.CC BY-NC · PubMed Central
Figure 2 Mean availability of 12 essential medicines for women, by facility type.
Figure 2 Mean availability of 12 essential medicines for women, by facility type.CC BY-NC · PubMed Central
Figure 3 Mean availability of 12 essential medicines for children, by facility type.
Figure 3 Mean availability of 12 essential medicines for children, by facility type.CC BY-NC · PubMed Central
Figure 4 Mean availability of 12 essential medicines for women, by facility location.
Figure 4 Mean availability of 12 essential medicines for women, by facility location.CC BY-NC · PubMed Central
Figure 5 Mean availability of 12 essential medicines for children, by facility location.
Figure 5 Mean availability of 12 essential medicines for children, by facility location.CC BY-NC · PubMed Central
Figure 6 Mean availability of 12 essential medicines for women, by facility ownership.
Figure 6 Mean availability of 12 essential medicines for women, by facility ownership.CC BY-NC · PubMed Central
Figure 7 Mean availability of 12 essential medicines for children, by facility ownership.
Figure 7 Mean availability of 12 essential medicines for children, by facility ownership.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 58

Metadata

Authors
Droti, B., O’Neill, K. P., Mathai, M., Yao Tsidi Dovlo, D., & Robertson, J.
Affiliations
  • World Health Organization (CH)
  • World Health Organization - Denmark (DK)
  • Health Systems and Services Cluster, World Health Organization, Regional Office for Africa, Brazzaville, Congo
  • World Health Organization Regional Office for Europe (DK)
Corresponding author
Droti, Benson
Venue
BMJ Global Health
Publisher
BMJ
Published
2019-10
Volume
4
Issue
Suppl 9
Pages
e001306
ISSN
2059-7908 (ISSN-L)
OpenAlex
W2978939006
Cited by
51
References
21
Citations by year
2026: 3 · 2025: 5 · 2024: 8 · 2023: 15 · 2022: 8 · 2021: 5 · 2020: 6 · 2019: 1
Type
conference abstract
Language
en
Open access
Licence
cc-by-nc
Locations
  • BMJ Global Health (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • NOVA (University of Newcastle Australia) (submittedVersion)
Funders
World Health Organization
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pharmaceutical Quality and Counterfeiting
Keywords
essential medicines availability, maternal health, child health, maternal mortality, under-five mortality, Sustainable Development Goal 3, sub-Saharan Africa, healthcare facilities, primary care, hospitals, urban-rural differences

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Poor availability of essential medicines for women and children threatens progress towards Sustainable Development Goal 3 in Africa. https://app.cochat.ai/papers/10.1136/bmjgh-2018-001306
The paper
Droti, B., O’Neill, K. P., Mathai, M., Yao Tsidi Dovlo, D., & Robertson, J. (2019). Poor availability of essential medicines for women and children threatens progress towards Sustainable Development Goal 3 in Africa. BMJ Global Health. https://doi.org/10.1136/bmjgh-2018-001306

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.